These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15328194)

  • 1. The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin.
    Dhillon VS; Aslam M; Husain SA
    Clin Cancer Res; 2004 Aug; 10(16):5537-45. PubMed ID: 15328194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
    Dhillon VS; Shahid M; Husain SA
    Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.
    Sood AK; Holmes R; Hendrix MJ; Buller RE
    Cancer Res; 2001 Jun; 61(11):4371-4. PubMed ID: 11389062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypermethylation of hMLH1 and microsatellite instability in ovarian mucinous tumors].
    Chen HZ; Ye DF; Xie X; Hu M; Lu WG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):457-61. PubMed ID: 12974095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
    Derks S; Postma C; Carvalho B; van den Bosch SM; Moerkerk PT; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
    Carcinogenesis; 2008 Feb; 29(2):434-9. PubMed ID: 18048385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of colorectal cancers in young patients based on chromosomal loss and microsatellite instability.
    Tada T; Watanabe T; Kanazawa T; Kazama S; Koketsu S; Nagawa H
    Scand J Gastroenterol; 2004 Nov; 39(11):1134-40. PubMed ID: 15545173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients.
    Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P
    Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypermethylation of promoter region of RASSF1A gene in ovarian malignant epithelial tumors].
    Ma L; Zhang JH; Liu FR; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):657-9. PubMed ID: 16438885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
    Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
    Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin.
    Dhillon VS; Young AR; Husain SA; Aslam M
    Br J Cancer; 2004 Feb; 90(4):874-81. PubMed ID: 14970867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
    Buller RE; Shahin MS; Holmes RW; Hatterman M; Kirby PA; Sood AK
    Am J Obstet Gynecol; 2001 Apr; 184(5):891-902; discussion 902-3. PubMed ID: 11303196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
    Walsh AM; Bailly GG; Bell DG; Norman RW; Gupta R; Zayed E; Nassar BA
    Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microsatellite instability in borderline ovarian tumors.
    Sanz Casla MT; Vidaurreta Lazaro M; Almansa de Lara I; Tresserra F; Lopez Marin L; Maestro ML; Dexeus S
    Anticancer Res; 2003; 23(6D):5139-41. PubMed ID: 14981979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.